Skip to main content
main-content

Zeitschrift

The journal of nutrition, health & aging

The journal of nutrition, health & aging 4/2009

Ausgabe 4/2009

Inhaltsverzeichnis ( 27 Artikel )

01.04.2009 | Editorial | Ausgabe 4/2009

Gerontology and geriatrics, a worldwide expansion in 2009: Data from the IAGG World Meeting Paris 2009, July 5–9th

B. Vellas, B. Forette

01.04.2009 | JNHA: Nutrition | Ausgabe 4/2009

Metabolic response to a ketogenic breakfast in the healthy elderly

E. Freemantle, M. Vandal, J. Tremblay-Mercier, M. Plourde, J. Poirier, S. C. Cunnane

01.04.2009 | Impact of Food Aid on Food Variety and Dietary Diversity | Ausgabe 4/2009

Impact of food aid on food variety and dietary diversity of an elderly community in Sharpeville, South Africa

W. H. Oldewage-Theron, R. Kruger

01.04.2009 | Awareness of Weight and Height | Ausgabe 4/2009

Unawareness of weight and height - the effect on self-reported prevalence of overweight in a population-based study

E. Ramos, C. Lopes, A. Oliveira, H. Barros

01.04.2009 | JNHA: Clinical Neurosciences | Ausgabe 4/2009

The association of thyroid stimulating hormone levels with cognitive function and depressed mood: The Rancho Bernardo study

D. Kritz-Silverstein, S. T. Schultz, L. A. Palinkas, D. L. Wingard, E. Barrett-Connor

01.04.2009 | Sleep Disorders and Their Impacts on Healthy, Dependent, and Frail Older Adults | Ausgabe 4/2009

Sleep disorders and their impacts on healthy, dependent, and frail older adults

Valérie Cochen, C. Arbus, M. E. Soto, H. Villars, M. Tiberge, T. Montemayor, C. Hein, M. F. Veccherini, S. -H. Onen, I. Ghorayeb, M. Verny, L. J. Fitten, J. Savage, Y. Dauvilliers, B. Vellas

01.04.2009 | Editorial | Ausgabe 4/2009

Use of biomarkers in Alzheimer’s trials

B. Vellas

01.04.2009 | Editorial | Ausgabe 4/2009

Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer’s disease

M. W. Weiner

01.04.2009 | Biomarkers for Alzheimer’s Disease Trials — Biomarkers for What? A Discussion Paper | Ausgabe 4/2009

Biomarkers for Alzheimer’s disease trials — biomarkers for what? A discussion paper

S. Lovestone, M. Thambisetty

01.04.2009 | JNHA: Clinical Trials and Aging | Ausgabe 4/2009

Interpreting biomarker data in therapeutic trials

P. S. Aisen

01.04.2009 | JNHA: Clinical Trials and Aging | Ausgabe 4/2009

Biomarkers in clinical trials of Alzheimer Disease (AD): What is expected from regulatory agencies?

C. Sampaio

01.04.2009 | JNHA: Clinical Trials and Aging | Ausgabe 4/2009

How can we recognize “disease modification” effects?

E. R. Siemers

01.04.2009 | Use of Biomarkers to Select the Target Population for Clinical Trials | Ausgabe 4/2009

Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment

P. J. Visser

01.04.2009 | Molecular Imaging Markers in Clinical Trials in Alzheimer’s Disease | Ausgabe 4/2009

Molecular imaging markers in clinical trials in Alzheimer’s disease

A. Nordberg

01.04.2009 | Neuro-Imaging: Structural and Functional Imaging | Ausgabe 4/2009

Neuro-imaging: Structural and functional imaging

G. B. Frisoni

01.04.2009 | Structural Imaging Markers for Therapeutic Trials in Alzheimer’s Disease | Ausgabe 4/2009

Structural imaging markers for therapeutic trials in Alzheimer’s disease

N. C. Fox, J. Kennedy

01.04.2009 | JNHA: Clinical Trials and Aging | Ausgabe 4/2009

Knowing the natural course of biomarkers in AD: Longitudinal MRI, CSF and PET data

W. M. Van Der Flier, P. Scheltens

01.04.2009 | Interest of the New Criteria for Drug Trials in AD | Ausgabe 4/2009

Interest of the new criteria for drug trials in AD

B. Dubois

01.04.2009 | Use of CSF Biomarkers in Alzheimer’s Disease Clinical Trials | Ausgabe 4/2009

Use of CSF biomarkers in Alzheimer’s disease clinical trials

K. Blennow, H. Zetterberg

01.04.2009 | What We Have Learned from the Myriad Trials | Ausgabe 4/2009

What we have learned from the myriad trials

S. B. Hendrix, G. K. Wilcock

01.04.2009 | JNHA: Clinical Trials and Aging | Ausgabe 4/2009

What we have learned from the xaliproden Sanofi-aventis trials

P. Douillet, J. -M. Orgogozo

01.04.2009 | JNHA: Clinical Trials and Aging | Ausgabe 4/2009

Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy

C. Wischik, R. Staff

01.04.2009 | The Alzhemed™ (Tramiprosate) Experience | Ausgabe 4/2009

Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer’s disease: The Alzhemedtm (Tramiprosate) experience

D. Saumier, P. S. Aisen, S. Gauthier, B. Vellas, S. H. Ferris, A. Duong, J. Suhy, J. Oh, W. Lau, D. Garceau, D. Haine, J. Sampalis

01.04.2009 | JNHA: Clinical Trials and Aging | Ausgabe 4/2009

Enrichment of MCI and early Alzheimer’s disease treatment trials using neurochemical & imaging candidate biomarkers

H. Hampel, K. Broich

01.04.2009 | The Validity of Biomarkers as Surrogate Endpoints in Alzheimer’s Disease | Ausgabe 4/2009

The validity of biomarkers as surrogate endpoints in Alzheimer’s disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)

C. C. Gispen-De Wied, M. Kritsidima, A. J. A. Elferink

01.04.2009 | JNHA: Geriatric Science | Ausgabe 4/2009

Defining frailty — the holy grail of geriatric medicine

S. Conroy

01.04.2009 | Frailty: Defining and Measuring of a Concept | Ausgabe 4/2009

Frailty: Defining and measuring of a concept

R. E. Pel-Littel, M. J. Schuurmans, M. H. Emmelot-Vonk, H. J. J. Verhaar

Aktuelle Ausgaben


 

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Herausgeber:
Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Herausgeber:
Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise